2 days ago
NBIX
AnalystsYigal NochomovitzYigal Nochomovitz's Stock Forecasts
AnalystsYigal Nochomovitz
Sectors:
Analyst Ranking
Top 6%
#278 out of 5342 analysts
Average Return
+10.34%
Win Rate
49%158 out of 325
Risk vs Reward
Poor
Good
Yigal Nochomovitz's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Applied Therapeutics IncAPLT | +640.00% | $0.80 | $5.92 | 2023-04-05 - 2024-04-04 | Strong Buy |
Harpoon Therapeutics IncHARP | +381.72% | $4.76 | $22.93 | 2023-09-18 - 2024-02-26 | Strong Buy |
Reata Pharmaceuticals IncRETA | +334.02% | $38.27 | $166.10 | 2022-11-09 - 2023-08-01 | Strong Buy |
Harpoon Therapeutics IncHARP | +327.80% | $5.36 | $22.93 | 2023-10-24 - 2024-02-26 | Strong Buy |
Summit Therapeutics IncSMMT | +293.31% | $5.31 | $20.89 | 2024-05-07 - 2024-09-27 | Strong Buy |
Yigal Nochomovitz Analyst Color
Get additional color on Yigal Nochomovitz's coverage of popular stocks
a month ago
ACAD
2 months ago
TVTX
2 months ago
STTK
2 months ago
TVTX
3 months ago
RIGL
3 months ago
NBIX
3 months ago
ARVN
3 months ago
AVBP
4 months ago
LGND
4 months ago
TVTX
4 months ago
NBIX
4 months ago
BMEA
4 months ago
LGND
4 months ago
ARVN
4 months ago
CADL
5 months ago
OLMA
5 months ago
DRTS
5 months ago
ARVN
5 months ago
IDYA
5 months ago
KRYS
6 months ago
NBIX
7 months ago
KRYS
7 months ago
ARDX
7 months ago
KRYS
Yigal Nochomovitz's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Neurocrine Biosciences IncNBIX | 6 | Strong Buy | $249.00 | +49.28% | Maintains | 2 days ago |
Ligand Pharmaceuticals IncLGND | 4 | Strong Buy | $387.00 | +34.59% | Reinstates | 12 days ago |
Acadia Pharmaceuticals IncACAD | 4 | Strong Buy | $35.00 | +35.29% | Maintains | a month ago |
Travere Therapeutics IncTVTX | 4 | Strong Buy | $70.00 | +25.25% | Maintains | 2 months ago |
Shattuck Labs IncSTTK | 8 | Strong Buy | $18.00 | +154.60% | Maintains | 2 months ago |
Mirum Pharmaceuticals IncMIRM | 1 | Strong Buy | $145.00 | +36.86% | Initiates Coverage On | 2 months ago |
Seaport Therapeutics IncSPTX | 1 | Strong Buy | $35.00 | +71.07% | Initiates Coverage On | 2 months ago |
Korro Bio IncKRRO | 1 | Strong Buy | $21.00 | +102.51% | Initiates Coverage On | 2 months ago |
Lenz Therapeutics IncLENZ | 6 | Strong Buy | $20.00 | +277.36% | Maintains | 3 months ago |
Arrivent Biopharma IncAVBP | 7 | Strong Buy | $43.00 | +44.20% | Maintains | 3 months ago |
Rigel Pharmaceuticals IncRIGL | 13 | Strong Buy | $81.00 | +120.05% | Maintains | 3 months ago |
Lexicon Pharmaceuticals IncLXRX | 8 | Strong Buy | $3.10 | +34.20% | Maintains | 3 months ago |
Zai Lab LtdZLAB | 9 | Strong Buy | $44.00 | +140.83% | Maintains | 3 months ago |
Crispr Therapeutics AgCRSP | 20 | Strong Buy | $82.00 | +70.87% | Maintains | 3 months ago |
Oric Pharmaceuticals IncORIC | 8 | Strong Buy | $16.00 | +44.53% | Maintains | 3 months ago |
Krystal Biotech IncKRYS | 12 | Strong Buy | $378.00 | +10.81% | Maintains | 3 months ago |
Arvinas IncARVN | 13 | Strong Buy | $24.00 | +198.88% | Maintains | 3 months ago |
Apellis Pharmaceuticals IncAPLS | 18 | Hold | $41.00 | -0.07% | Downgrades | 4 months ago |
Biomea Fusion IncBMEA | 12 | Strong Buy | $7.00 | +498.29% | Maintains | 4 months ago |
Sarepta Therapeutics IncSRPT | 3 | Strong Sell | $13.00 | -12.52% | Maintains | 4 months ago |
Candel Therapeutics IncCADL | 4 | Strong Buy | $26.00 | +159.74% | Maintains | 4 months ago |
Zenas Biopharma IncZBIO | 3 | Strong Buy | $41.00 | +30.41% | Maintains | 5 months ago |
Olema Pharmaceuticals IncOLMA | 4 | Strong Buy | $62.00 | +441.48% | Maintains | 5 months ago |
Alpha Tau Medical LtdDRTS | 2 | Strong Buy | $9.00 | -23.66% | Maintains | 5 months ago |
Eyepoint IncEYPT | 2 | Strong Buy | $35.00 | +185.71% | Maintains | 5 months ago |
Arcus Biosciences IncRCUS | 9 | Strong Buy | $45.00 | +59.63% | Maintains | 5 months ago |
Arcturus Therapeutics Holdings IncARCT | 10 | Hold | $8.00 | +38.89% | Maintains | 5 months ago |
Spyglass Pharma IncSGP | 1 | Strong Buy | $42.00 | +86.42% | Initiates Coverage On | 5 months ago |
Syndax Pharmaceuticals IncSNDX | 10 | Strong Buy | $57.00 | +199.21% | Maintains | 5 months ago |
Ideaya Biosciences IncIDYA | 4 | Strong Buy | $65.00 | +83.10% | Maintains | 5 months ago |
Ardelyx IncARDX | 13 | Strong Buy | $14.00 | +182.83% | Maintains | 7 months ago |
Beone Medicines LtdONC | 5 | Strong Buy | $405.00 | +28.16% | Maintains | 9 months ago |
Solid Biosciences IncSLDB | 2 | Strong Buy | $14.00 | +73.70% | Maintains | 9 months ago |
Caribou Biosciences IncCRBU | 6 | Strong Buy | $8.00 | +447.95% | Maintains | 9 months ago |
Summit Therapeutics IncSMMT | 6 | Strong Buy | $40.00 | +207.22% | Maintains | 9 months ago |
Merus NvMRUS | 15 | Hold | $97.00 | +7.78% | Downgrades | 10 months ago |
Zymeworks IncZYME | 13 | Strong Buy | $22.00 | +0.27% | Maintains | a year ago |
Prokidney CorpPROK | 2 | Strong Buy | $9.00 | N/A | Maintains | a year ago |
Applied Therapeutics IncAPLT | 8 | Strong Buy | $8.00 | N/A | Maintains | 2 years ago |
Macrogenics IncMGNX | 10 | Strong Buy | $14.00 | N/A | Maintains | 2 years ago |
Ovid Therapeutics IncOVID | 6 | Hold | $1.20 | N/A | Maintains | 2 years ago |
Calliditas Therapeutics AbCALT | 2 | Hold | $39.00 | N/A | Downgrades | 2 years ago |
Proqr Therapeutics NvPRQR | 3 | Hold | $2.00 | N/A | Maintains | 2 years ago |
Harpoon Therapeutics IncHARP | 9 | Hold | $23.00 | N/A | Downgrades | 2 years ago |
Mirati Therapeutics IncMRTX | 11 | Hold | $59.00 | N/A | Downgrades | 3 years ago |
Aldeyra Therapeutics IncALDX | 8 | Strong Buy | $8.00 | N/A | Maintains | 3 years ago |
Rain Oncology IncRAIN2 | 4 | Hold | $1.00 | N/A | Maintains | 3 years ago |
Eiger Biopharmaceuticals IncEIGRQ | 3 | Strong Buy | $90.00 | N/A | Maintains | 3 years ago |
Gracell Biotechnologies IncGRCL | 2 | Strong Buy | $11.00 | N/A | Maintains | 3 years ago |
Galera Therapeutics IncGRTX | 2 | Hold | $0.25 | N/A | Maintains | 3 years ago |
Atara Biotherapeutics IncATRA | 11 | Strong Sell | $35.00 | N/A | Maintains | 3 years ago |
Reata Pharmaceuticals IncRETA | 8 | Hold | $172.50 | N/A | Downgrades | 3 years ago |
Ultragenyx Pharmaceutical IncRARE | 10 | Strong Buy | $133.00 | N/A | Maintains | 3 years ago |
Unity Biotechnology IncUNBX | 6 | Strong Buy | $6.00 | N/A | Maintains | 3 years ago |
Cellectis SaCLLS | 2 | Strong Buy | $16.00 | N/A | Maintains | 3 years ago |
Fate Therapeutics IncFATE | 3 | Strong Buy | $10.00 | N/A | Maintains | 3 years ago |
Opthea LtdOPTEY | 2 | Strong Buy | $44.00 | N/A | Maintains | 4 years ago |
Innate Pharma SaIPHA | 1 | Strong Buy | $12.00 | N/A | Maintains | 4 years ago |
Aerie Pharmaceuticals IncAERI | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Dicerna Pharmaceuticals IncDRNA | 2 | Hold | $32.00 | N/A | Downgrades | 5 years ago |
Acceleron Pharma IncXLRN | 1 | Strong Buy | $171.00 | N/A | Maintains | 5 years ago |
Puma Biotechnology IncPBYI | 5 | Strong Buy | $70.00 | N/A | Maintains | 7 years ago |
Loxo Oncology IncLOXO | 6 | Strong Buy | $213.00 | N/A | Maintains | 8 years ago |
Keryx Biopharmaceuticals IncKERX | 2 | Hold | $4.00 | N/A | Maintains | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.